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Background: Low back pain is a prevalent and debilitating condition that affects the health and quality of life of
older adults. Older people often consult primary care physicians about back pain, with many also receiving
concurrent care from complementary and alternative medicine providers, most commonly doctors of chiropractic.
However, a collaborative model of treatment coordination between these two provider groups has yet to be
tested. The primary aim of the Collaborative Care for Older Adults Clinical Trial is to develop and evaluate the
clinical effectiveness and feasibility of a patient-centered, collaborative care model with family medicine physicians
and doctors of chiropractic for the treatment of low back pain in older adults.
Methods/design: This pragmatic, pilot randomized controlled trial will enroll 120 participants, age 65 years or older
with subacute or chronic low back pain lasting at least one month, from a community-based sample in the
Quad-Cities, Iowa/Illinois, USA. Eligible participants are allocated in a 1:1:1 ratio to receive 12 weeks of medical care,
concurrent medical and chiropractic care, or collaborative medical and chiropractic care. Primary outcomes are
self-rated back pain and disability. Secondary outcomes include general and functional health status, symptom
bothersomeness, expectations for treatment effectiveness and improvement, fear avoidance behaviors, depression,
anxiety, satisfaction, medication use and health care utilization. Treatment safety and adverse events also are
monitored. Participant-rated outcome measures are collected via self-reported questionnaires and
computer-assisted telephone interviews at baseline, and at 4, 8, 12, 24, 36 and 52 weeks post-randomization.
Provider-rated expectations for treatment effectiveness and participant improvement also are evaluated. Process
outcomes are assessed through qualitative interviews with study participants and research clinicians, chart audits of
progress notes and content analysis of clinical trial notes.
Discussion: This pragmatic, pilot randomized controlled trial uses a mixed method approach to evaluate the
clinical effectiveness, feasibility, and participant and provider perceptions of collaborative care between medical
doctors and doctors of chiropractic in the treatment of older adults with low back pain.
Trial registration: This trial registered in ClinicalTrials.gov on 04 March 2011 with the ID number of NCT01312233.
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Low back pain (LBP) is a recognized public health problem
impacting millions of people worldwide. Recent prevalence
studies estimate that between one-quarter to one-third of
all U.S. adults experience LBP during a three-month time
period [1-3]. Studies on the natural history of LBP depict
an episodic trajectory of recurrence and recuperation for
most people [4], with less than 15% of LBP sufferers either
making a complete recovery or experiencing long-term
disability at five-years [5]. However, the prevalence of
chronic LBP has risen substantially, with an increase in
LBP healthcare seeking from 73% in 1992 to 84% in 2006.
These increases were documented across all adult age
categories [6]. Healthcare expenditures for persons with
spine problems also have risen 65% (adjusted for inflation)
in the past decade while the impact of spine problems has
increased over this same time period [7].
While adults over the age of 65 report LBP prevalence
rates similar to persons in the age 45 to 65 age demo-
graphic [2,8], the sequelae of back pain in this patient
population may have a greater impact on physical function
and quality of life than back pain in younger age groups
[9,10]. Community-dwelling seniors with LBP have an
increased risk of falling, more problems with activities of
daily living, such as walking, lifting objects or bathing,
greater difficulties in social interaction [9] and are more
likely to report depression, poor sleep quality, and more
medication use, and to demonstrate decreased performance
on functional status tests than pain-free elders [10].
LBP also is among the most common reasons people,
including older adults, seek healthcare, either from pri-
mary care medical providers [11,12] or complementary
and alternative medicine (CAM) practitioners, including
doctors of chiropractic (DCs) [13-16]. As such, LBP in
older adults presents as an exemplary condition for
assessing the feasibility, efficacy, cost-effectiveness, and
patient and provider satisfaction with integrative
approaches to chronic disease management [17-19].
CAM users note higher levels of satisfaction with their
LBP care than do the patients of conventional medical
providers [20,21]. Few studies have reported the effect-
iveness of either primary care treatments [22,23] or
chiropractic care [24-28] that include older adults with
LBP, much less how these treatments might be
combined effectively and safely in this population. The
largest controlled trial to date comparing conservative
medical management of LBP with two forms of spinal
manipulation in 240 patients aged 55 years and older
(mean age 63.1 years, SD 6.7) reported higher rates of
functional improvement in patients receiving spinal
manipulation, with few treatment side effects and no
serious adverse effects reported [27].
However, recent studies of care coordination between
medical doctors (MD) or doctors of osteopathy (DO)and doctors of chiropractic suggest low patterns of refer-
ral or co-management between these provider groups
for patients with musculoskeletal conditions [17,29-31].
Among 7,447 Medicare recipients, the percent of
episodes of chiropractic-sensitive conditions in which an
older adult concurrently visited a DC and another
healthcare professional, such as a primary care provider,
diagnostic radiologist, orthopedist, anesthesiologist or
physical therapist, ranges from 4.9% to 10.9% [32].
Older adults use a variety of self-care, conventional
and complementary therapies, including chiropractic
care, for pain management, LBP care and treatment of
other musculoskeletal conditions [33] as well as for
other common symptoms [34]. When concurrent care
for older adults with back pain does occur, the patient is
often the unit of integration between CAM practitioners
and medical physicians, rather than the providers them-
selves [35]. Problematically, older adult patients may not
discuss their use of CAM therapies with their healthcare
providers [36], and the use of these therapies may not be
documented in medical records [37,38]. When MD/DOs
and DCs do make formal referrals to one another, these
providers may not exchange important clinical information,
such as the patient’s health history, medications, X-ray or
laboratory reports, or treatment plans, with one another to
facilitate integrative care [30,31,39].
Hsiao and colleagues argue that the appropriate unit
of integration for patients seeking care from both CAM
practitioners and primary care professionals is at the
provider level, not the patient level [35,40]. Four
domains for integration between CAM providers and
conventional healthcare professionals have been identified:
attitudes, knowledge, referral and practice [35]. Similarly,
Boon et al. present a conceptual framework with seven
team-oriented care models ranging from parallel practice to
fully integrative, non-hierarchical holistic approaches to
practicing patient-centered integrative health care [41,42].
While previous studies have compared LBP outcomes for
patients receiving either medical care or chiropractic care
[27,43,44], few examples of interdisciplinary medical and
chiropractic practice are reported in the literature [45-48],
with none evaluating patient-centered outcomes from
various clinical practice models of MD/DO and DC colla-
boration, particularly in the older adult population.
This paper describes the study protocol for the
Collaborative Care for Older Adults (COCOA) Study, a
prospective, pragmatic, pilot randomized controlled
trial designed to compare the clinical effectiveness of
three professional practice patterns for the treatment of
adults age 65 years and older with subacute or chronic
LBP: 1) conventional medical care alone (Med Care); 2)
concurrent medical and chiropractic care (Dual Care);
and 3) collaborative medical and chiropractic care
(Shared Care). Participants in all three groups receive
Goertz et al. Trials 2013, 14:18 Page 3 of 18
http://www.trialsjournal.com/content/14/1/18individualized LBP treatments supported by discipline-
specific best practice recommendations for the care of
older persons with back pain [49-51].Primary aim
The primary aim of this pilot study is to evaluate the
feasibility and collect preliminary data on the clinical
effectiveness of a MD/DO and DC collaborative care
model for the treatment of LBP in adults aged 65 years
or older. Self-reported back pain and disability are the
primary patient-centered outcome measures for this
study and the primary endpoint is at 12 weeks [52].Secondary aims
The secondary aims are to determine the clinical effect-
iveness of the three interventions using the following
participant-rated outcomes: general health status, fear
avoidance behaviors, symptom bothersomeness, depression
and anxiety, expectations, improvement, satisfaction, health
care utilization, and medication use, with functional status
objectively assessed with a brief walking test. Provider-rated
expectations for treatment effectiveness and participant
improvement in LBP, general health and quality of life will
also be measured. As this is a pilot study, the feasibility of
the collaborative care model and other clinical trial process
outcomes are assessed through qualitative interviews
conducted at week 12 with study participants and with
research clinicians at the end of their participation in the
project. Chart audits of clinician progress notes, and
content analysis of clinical trial process notes will also be
conducted.Methods and design
Ethics approval
The Institutional Review Boards (IRB) of the Palmer
College of Chiropractic (IRB# 2011 G138 – January 19,
2011) and Genesis Health System (IRB# 11–005 – January
28, 2011) reviewed the study protocol and informed
consent document and approved the human research
participant protection procedures for this trial. The IRBs
approve all study protocol amendments and review report-
able adverse events throughout the trial. Research clinicians
(MDs, DOs and DCs), study coordinators (SCs), the project
manager and research nurse, and clinic-based investigators
complete the National Institutes of Health (NIH) on-line
research ethics training course, Protecting Human Research
Participants, before interaction with study participants and
then on an annual basis, while other investigators complete
human subjects training as outlined by their primary
appointment institution [53]. Written informed consent is
obtained from all study participants.Design overview
The COCOA Study is a prospective, pragmatic, pilot
randomized controlled trial [54-56]. Pragmatic clinical
trials are designed and ‘aligned with the purpose of
comparative effectiveness research’ (p. 208), that is, they
enroll patients with diverse background characteristics
and common co-morbidities, deliver interventions com-
mon in clinical practice, and evaluate patient-centered,
clinically-relevant outcome measures [56]. In the
COCOA Trial, we are enrolling approximately 120 parti-
cipants 65 years old or older who report subacute or
chronic LBP of a minimum duration of one month.
Eligible participants are randomized to one of three
parallel treatment groups: 1) conventional medical care
provided by a family medicine physician, 2) concurrent
medical and chiropractic care provided by an unlinked
family medicine physician and a doctor of chiropractic,
and 3) collaborative medical and chiropractic care pro-
vided by a family medicine physician and a doctor of chiro-
practic who comprise a patient-centered, co-management
team (Figure 1). The collaborative care professionals
engage in the following practices to foster interdisciplinary
practice: 1) research record sharing via a secure Doctor
Communications module specifically constructed and
maintained for this study within a web-based Submission,
Tracking and Reporting System (STaRS), 2) interprofes-
sional telephone consultations, and 3) patient-centered
treatment planning and evaluation. Participants receive up
to 12 weeks of individualized, evidence-based medical and/
or chiropractic treatments for their back pain [49,50].
Our primary outcome measures are self-reported
LBP, measured on an 11-point numerical rating scale,
(NRS) [57], and disability measured by the Roland
Morris Disability Questionnaire (RMDQ) [58] at week
12. Secondary outcomes include general and functional
health status, fear avoidance behaviors, symptom bother-
someness, depression and anxiety, expectations, improve-
ment, satisfaction, health care utilization and medication
use. Participant self-report outcomes are measured in per-
son at baseline and 12 weeks, with a subset of outcomes
completed at weeks 4 and 8 via computer-assisted tele-
phone interviews (CATI). After the primary endpoint at
week 12, we continue to follow participants on selected
outcome measures every three months for up to one year
(weeks 24, 36 and 52) by CATI. In addition to clinical out-
comes, we are describing process outcomes associated
with implementing this project across family medicine
and chiropractic clinics. We are also assessing participant
and provider perceptions of the collaborative care model
and the clinical trial design with nested qualitative studies.
Research settings
This trial is being conducted by investigators and staff at
the Palmer Center for Chiropractic Research (PCCR)
0-2 wks
Questionnaires
2-4 wks
0-1 wk
MED CARE
Medical Treatments
(n = 40)
DUAL CARE
Separate Medical and 
Chiropractic Treatments
(n = 40)
SHARED CARE 
Shared Medical and 
Chiropractic Treatments
(n = 40)
Baseline Visit 2 - GFMC
MD/DO Exam
Case Review - PCCR
Final Eligibility Consensus
Baseline 3 CATI - PCCR
Eligibility CATI + Questionnaire
Treatment Group Allocation
 DC Appointment Scheduling
Phone Call - GFMC
 MD/DO Appointment Scheduling
Telephone Screen CATI - PCCR
Baseline Visit 1 - PCCR
Informed Consent
Interviews
DC Exam + Timed Up & Go + X-rays
Week 12 Evaluation - GFMC
Questionnaires
MD/DO Exam
Week 12 Evaluation - PCCR
Questionnaires
DC Exam + Timed Up & Go
Exit Interviews
Follow-Up CATI - PCCR
Every 3 Months up to 1 Year (Weeks 36, 48, 52)
All Treatment Groups - GFMC
MD/DO Treatment Visits + Questionnaires
(Up to 12 Weeks)
Dual Care/Shared Care - PCCR
DC Treatment Visits + Questionnaires
(Up to 12 Weeks)
Outcomes CATI - PCCR
Week 4 & Week 8 
Figure 1 Participant flow chart. CATI, Computer-assisted telephone interview. DC, Doctor of Chiropractic. DO, Doctor of Osteopathy. GFMC,
Genesis Family Medical Center. MD, Medical Doctor. PCCR, Palmer Center for Chiropractic Research.
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Iowa, USA. Investigators at The University of Iowa College
of Public Health and Thomas Jefferson University Center
for Collaborative Research assisted in the design of the
clinical study and provide ongoing oversight to the clinical
trial through monthly steering committee meetings. Inves-
tigators at all four institutions will be involved in data
interpretation and the manuscript writing process.
The PCCR was established in 1995 to conduct chiro-
practic basic science and clinical research. The Office of
Data Management and Biostatistics at the PCCR serves
as the data coordinating center (DCC) and will conduct
the primary data analysis. The Palmer Research Clinic(PRC) of the PCCR is leading participant recruitment
efforts, administering the informed consent process,
collaborating on baseline assessments, leading the case
review process for eligibility determination, contributing
to two treatment arms and conducting follow-up
assessments.
GFMC is the community-based location of a family
medicine residency program accredited by the Ac-
creditation Council for Graduate Medical Education
that provides a three-year, post-graduate training pro-
gram for qualified medical doctors and doctors of
osteopathy. The DOs training in this family medicine
program are supervised by family medicine medical
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nipulative therapy. GFMC is assisting in participant re-
cruitment, collaborating on baseline assessment and
eligibility determination, and contributing to all three
treatment arms. Both clinics will monitor and address
adverse events throughout the study.
Study population
Participants are recruited from the Quad Cities metro-
politan area and select cities in contiguous rural counties
of Iowa and Illinois located within 50 miles of the study
sites. This region has a combined census count of approxi-
mately 568,000 residents, with persons aged 65 years or
older comprising 13 to 18% of various county populations
[59]. Our target population includes adults aged 65 years
and older who currently report subacute or chronic LBP of
at least one month duration. We plan to enroll approxi-
mately 120 participants for this trial.
Inclusion criteria
Individuals must be at least 65 years of age with a
current episode of LBP lasting at least one month in
duration to volunteer for this clinical trial. Participants
must demonstrate an ambulatory mobility status by suc-
cessful completion of the Timed Up and Go Test [60].
Participants also must be willing to enroll in this study
regardless of treatment group allocation and provide
written informed consent to participate.
In addition to the above inclusion criteria, participants
must have a chief complaint of LBP that fits classifica-
tions 1 to 9 of the Report of the Quebec Task Force (QTF)
on Spinal Disorders (see Table 1) [61]. The treating MDs/
DOs and DCs may prescribe or offer LBP treatments
within their scope of practice and as recommended by best
practice or clinical guideline recommendations. Thus, the
QTF classifications in this study are broader than those in
other studies of chiropractic care conducted at the PCCRTable 1 Quebec task force on spinal disorders classification s
QTF category Description
1 Pain without radiation
2 Pain + radiation to extremity, proximally
3 Pain + radiation to extremity, distally
4 Pain + radiation to upper/lower limb with neu
5 Presumptive compression of a spinal nerve roo
6 Compression of a spinal nerve root confirmed
tomography or magnetic resonance imaging)
7 Spinal stenosis
8 Postsurgical status, one to six months after int
9 Postsurgical status, more than six months afte
10 Chronic pain syndrome
11 Other diagnoses (metastases, visceral disease,which were designed to either evaluate treatment effective-
ness of specific spinal manipulative techniques [27,62] or
within a particular subgroup of LBP patients [63].
Exclusion criteria
Participants are excluded if they self-report LBP scores of
less than 4 on the 11-point NRS at Phone Screen or the
Baseline 1 (BL1) Interview or less than 2 at the Baseline 3
(BL3) CATI. LBP diagnosed as Quebec Task Force clas-
sifications [61] 10 (chronic pain syndrome) or 11 (other
non-musculoskeletal diagnoses) are excluded from this
study as these conditions either require additional
evaluation or management provided by healthcare pro-
fessionals outside of the study doctors. Participants who
self-report spinal surgery in the past three months or
bone fracture in the past six weeks, or who are identi-
fied as presenting with a bone or joint pathology
(including metastatic bone disease) contraindicating
chiropractic care are excluded [64]. Participants are
excluded if they self-report any treatment of LBP by a
healthcare provider in the past two months or if they
are unwilling to avoid LBP treatment from non-study
clinicians unless prescribed by their treating clinician
during the 12-week trial treatment phase.
Participants also are excluded for the following medical
or health status conditions: metastatic disease requiring
active treatment; concomitant illness, co-morbidity,
mental health conditions, and/or activity of daily living,
sensory or mobility impairments that require additional
testing, treatment or referral to outside providers, pose
safety risks, and/or necessitate coincident medical
treatment considered burdensome by the participant;
pregnancy; aortic aneurysm of more than five centimeters;
daily use of a wheelchair or motorized scooter for locomo-
tion; memory impairment as assessed by the examining
clinician during baseline evaluation; or self-reported
alcohol or substance dependence or abuse. Participantsystem [61]
rologic signs
t on a simple roentgenogram (that is, spinal instability or fracture)
by specific imaging techniques (that is, myelography, computerized axial
ervention
r intervention
recent compression fracture, spondylitis)
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are provided with a copy of their baseline evaluation, re-
ferral letters (as indicated) and clinical recommendations.
Also exclusionary are current or pending litigation for
a work-related injury or personal injury case for LBP;
current student, employee or faculty member of Palmer
College of Chiropractic or GFMC; current nursing home
residence; transportation difficulties; plans to move from
the Quad-Cities area during the four months of baseline
evaluation and active care; concurrent enrollment in this
study by another member of the same household; inability
to speak, read or write in English; proxy required to
complete any component of the pre-randomization process;
or other compliance concerns noted at case review.
Participant recruitment
Recruitment began in March 2011 with invitation letters
sent to current GFMC patients aged 65 years or older
who were diagnosed with either of two International
Classification of Diseases, 9th Revision (ICD-9) [65] back
pain codes (724.2 lumbago and 724.5 backache unspeci-
fied) from July 2009 through January 2011. The invita-
tional letter provided an overview of the study and
included contact information for calling the PRC if inter-
ested in learning more about the study. Invitational let-
ters are also periodically sent to GFMC patients who
have recently turned 65 years of age. We also recruit
GFMC patients who make visits to their primary care
provider for back pain during the study enrollment
period. Brochures and flyers are posted at GFMC, PRC
and disseminated in campus-wide announcements at the
chiropractic college. Additional community-based re-
cruitment strategies include brochure placement in com-
munity settings; presentations at community, senior
citizen and health-related events and venues; and press
releases, articles, and advertisements in local media out-
lets. Finally, targeted postcard mailers are sent to older
adults living within approximately 50 miles of Daven-
port, Iowa, using a commercial direct mail service [66].
Based upon previous studies conducted by the PCCR in
this patient population, we anticipate the inclusion of
women and minorities in this clinical trial will be pro-
portional to that in the Quad Cities area [27,66].
Eligibility determination
It is required that all participants be evaluated by both a
doctor of chiropractic and a medically trained physician
prior to enrollment as part of our multi-stage eligibility
determination process. Interested individuals first con-
tact the PCCR by phone or with the return of a pre-
stamped postcard. A staff member administers a short
CATI to screen for provisional eligibility and, if the indi-
vidual is eligible and interested, schedules the volunteer
for a BL1 Visit. The study volunteer is mailed a homepacket consisting of an introduction letter, appointment
reminder with checklist and data collection forms,
including demographics, past medical, back pain and
chiropractic treatment history, chiropractic beliefs, and
health assessments to complete before the BL1 Visit. An
appointment reminder phone call is provided the day
before the BL1 Visit.
At the BL1 Visit, a SC reviews the informed consent
document, flow chart and visit activities with the study
volunteer. The study volunteer watches a short video of
study procedures, reads the informed consent document
and asks questions. Volunteers who do not wish to
enroll are thanked for their interest and observe the SC
shred the home packet documents in assurance that
their protected health information is not used in the
study. For participants who sign the written informed
consent document, a SC measures the vital signs, height
and weight. The participant then completes primary and
secondary outcome measurements and a treatment
expectations questionnaire. The SC reviews the forms
for incomplete data and completes a computer-based
form programmed with eligibility criteria. If eligible, the
participant completes a medication review, current pain,
depression [67] and anxiety [68] questionnaires, and a
substance use assessment form to screen for tobacco,
alcohol [69] and illicit drug [70] use.
A DC then reviews all health-related research docu-
ments, noting areas where further information is needed
from the participant or via examination to determine eli-
gibility status or the need for referral. The DC gathers a
focused LBP history, conducts an eligibility examination,
including a mobility assessment [60] and the World
Health Organization Fracture Risk Assessment Tool to
evaluate fracture risk [71], and reviews and scores screen-
ing questionnaires for depression, anxiety and substance
abuse. A dipstick urinalysis (Siemens MultistixW 10 SG,
Tannytown, NY, USA) is performed, as indicated. Lumbar
spine X-rays may be completed when recent imaging find-
ings are not available to assist in diagnosis, evaluate for the
presence of pathology and provide information regarding
the safety of available procedures [72]. The lumbar X-rays
taken for this study are read and evaluated by the Director
of Clinical Radiology at Palmer College of Chiropractic, a
DC who has earned a Diplomate from the American
Chiropractic Board of Radiology and who is not a member
of the research study clinical staff. Additional examinations
include auscultation to screen for abdominal aortic
aneurysm and assessment of ankle-brachial index for parti-
cipants with signs or symptoms of peripheral vascular dis-
ease. If additional laboratory procedures or diagnostic tests
are required to evaluate the participant’s LBP or health sta-
tus, he or she is excluded from the study and referred to
an appropriate healthcare provider for follow-up. With
the consent of the participant, health records from outside
Goertz et al. Trials 2013, 14:18 Page 7 of 18
http://www.trialsjournal.com/content/14/1/18institutions may be requested and reviewed as part of the
eligibility determination.
After the BL1 Visit, the DC completes a web-based
eligibility form and writes a brief baseline examination
summary which includes demographics, LBP chief
complaint, pain profile, health history, X-ray findings,
working diagnoses, red flag conditions, and eligibility
and clinical concerns for further assessment by the
family medicine physician. The BL1 Visit web-based
eligibility form includes prompts for the clinician to
comment on specific exclusion criteria in a systematic
process for each participant as well as an open text field
in which to address other possible eligibility concerns.
The baseline summary, any outside records and the X-ray
report are uploaded to the password protected Doctor
Communications web module. These documents and the
BL1 Visit eligibility form are reviewed by GFMC physicians
before the Baseline 2 Visit.
Participants deemed eligible for further evaluation
following the BL1 Visit receive a second eligibility
screening exam (Baseline Visit 2-BL2) by a medical or
osteopathic physician at the GFMC to assess their gen-
eral health status, LBP and study eligibility. This exam
focuses on age-related concerns such as memory pro-
blems, prescription and non-prescription medications,
mobility and functional limitations, depression or other
mental health concerns, health concerns or findings
identified at the BL1 requiring further evaluation by the
GFMC doctor, and the LBP chief complaint. The BL2
MD/DO examiner evaluates the participant for other
conditions commonly seen in older adults and considered
as possible exclusionary criteria, such as cardiovascular dis-
ease (abdominal aortic aneurysms, congestive heart failure,
and so on) and systemic or organic diseases (infections,
cancer, renal or liver impairment, endocrine diseases, and
so on). The GFMC physician also completes a web-based
eligibility form that includes systematic questions on key
eligibility criteria, red flag conditions and open comment
fields for additional concerns, and writes the LBP-focused
case summary. The GFMC research nurse uploads the case
summary document to the password protected Doctor
Communications module before Case Review.
Case Review is a twice weekly meeting held at the
PCCR that relies upon the combined experience and ex-
pertise of DC clinicians, SCs and project managers to: 1)
facilitate consistent interpretation and application of the
pre-defined eligibility criteria; 2) identify possible red
flag conditions, compliance issues, safety concerns, treat-
ment precautions and recommendations for further
evaluation or referral; and 3) reach consensus on the parti-
cipant’s final eligibility status and primary, secondary and
co-morbid diagnoses. The research center has used a simi-
lar case review process to determine study eligibility of
more than 1,100 interested participants in a previous RCTthat allocated 221 participants to three treatment groups
evaluated the effect of spinal manipulation on sensorimotor
functions in back pain patients [62], as well as for clinical
trials evaluating medical and chiropractic care for persons
aged 55 and older [27,66] and chiropractic care and self-
care for back-related leg pain [63].
Briefly, the examining DC clinician provides a verbal
presentation and leads a group discussion on the case
focusing on the past medical history and clinical presen-
tation, X-ray findings, and the web-based eligibility
reports from the BL1 and BL2 visits conducted by the
DC and MD/DO respectively, compliance and safety
concerns, diagnosis and eligibility determination. An
electronic manual of operating procedures is available to
reference inclusion and exclusion criteria, operational
definitions and study protocols to support consistent eli-
gibility determination decisions, based upon the specific
eligibility criteria (for example, aneurysm, carcinoma or
metastatic disease, cognitive impairment, alcohol or drug
abuse, recent spinal surgery or fracture, QTF classifica-
tion, safety concerns, and so on) considered for each
participant at the Case Review stage of this multi-staged
eligibility determination process. Consensus on final eli-
gibility occurs when 80% of the clinicians present agree
with the determination decision. If consensus is not
reached, the senior clinician will render final eligibility
determination. Once eligibility consensus is reached, a
Case Review web module programmed with explicit exclu-
sion criteria is completed for each participant and the eligi-
bility decision, along with the reasons for exclusion and
comments regarding the Case Review process, is recorded
and saved in the Participant Tracking and CONSORT
web-modules of the STaRs. An automated e-mail notifica-
tion is sent to the SCs to contact the participant for treat-
ment group allocation (BL3 CATI). After Case Review, the
examining DC calls any participant who is ineligible for
study treatments to inform him or her of this determin-
ation, review examination findings and offer follow-up
recommendations.
Randomization
Treatment allocation occurs through a 1:1:1 ratio by a pre-
determined, computer-generated, restricted randomization
scheme with random block sizes of three or six allocating
participants to one of three treatment groups: a) Med
Care, b) Dual Care, or c) Shared Care. Study personnel are
blinded to upcoming treatment group allocation. A SC at
the PRC accesses the treatment allocation module in the
STaRS, selects the participant ID, completes the BL3 CATI
to determine the participant’s continued interest in the
study and final eligibility for participation, and requests
the treatment group allocation. Date and time of the allo-
cation, SC USERID and treatment group allocation are
stored automatically in the project database. If the web
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treatment allocation protocol is administered by predeter-
mined sequentially numbered, opaque envelopes stored in
a locked cabinet in a secure location. The participant is
told his or her treatment group allocation and then
answers a three-item questionnaire about their expecta-
tions for back pain improvement, general health status
and quality of life. If the participant is allocated to the
Dual Care or Shared Care groups, he or she is scheduled
for the first DC treatment visit at the PRC. The GFMC
Research Nurse receives an automated e-mail notification
of the participant’s treatment group allocation and makes
a phone call to schedule the first treatment visit at GFMC.
Study treatments
Participants in all three treatment groups receive up to
12 weeks of standard back pain care from a family medi-
cine physician, while participants assigned to the Dual
Care and Shared Care groups also receive up to 12
weeks of chiropractic care. Participants are requested
not to seek additional back pain care from non-study
providers during the 12 weeks of active care, unless the
trial doctors prescribe or recommend such treatments
(for example, physical therapy, exercise classes, massage,
pain clinic referral). Providers query participants about
any outside healthcare appointments, changes in pre-
scribed treatments or self-care activities, and new or
resolved symptoms, injuries or adverse effects from
study interventions at each treatment visit, with any
such changes in health status documented in the paper-
based (at PCCR) or electronic (at GFMC) progress
notes. Participants are encouraged to continue receiving
healthcare for any non-back pain related acute ailments
or chronic conditions from their usual primary care
providers or medical specialists. In order to limit X-ray
exposure among participants, X-ray reports (and images
upon request) are exchanged between clinics. The study
interventions and availability of other health records are
described in further detail below.
Medical care
All study participants receive conventional medical care
from a family medicine resident who is supervised by
on-site family medicine physician faculty at the GFMC.
Medical care provided in this study includes standard
therapies for back pain that occur over a 12-week time
period. None of the medical treatments in this study are
experimental. GFMC physicians follow the Joint Clinical
Practice Guideline from the American College of Physicians
and the American Pain Society [51]. The key principles of
these recommendations include: a focused history and
physical examination; limited diagnostic imaging restricted
to select patients (that is, radiculopathy); education about
self-management, including maintaining activity levels astolerated, local heat or cold application, and exercises;
pharmacologic management with the use of analgesics and
anti-inflammatory agents; and additional therapies that may
be applied for participants not responding to the initial
interventions, including physical therapy and referral to a
pain clinic. All medical care visits are staffed by attending
physicians in addition to the resident physicians who are
assigned to study participants.
Participants, their insurance company or Medicare are
charged for the medical care delivered during the 12
weeks of active care. The minimum dose of conventional
medical care for this study is one treatment visit to the
family practice doctor. Medical care treatment visits last
approximately 15 minutes, with additional visits scheduled
as needed. Participants allocated to the Dual Care and Med
Care groups receive medical care from a different subset of
GFMC physicians than do the participants allocated to col-
laborative care treatments provided by Shared Care doctors
(described below).
Chiropractic care
Participants assigned to either the Dual Care or Shared
Care groups receive chiropractic care at the PCCR
Research Clinic for up to 12 weeks. Unlike clinical trials
[62,63,73,74] or observational studies [75] of spinal
manipulative therapy or other chiropractic techniques,
including studies previously conducted with older adult
populations [27], clinicians in this study are not limited
to any specific type of chiropractic care. This pragmatic
design allows clinicians to tailor treatments to the parti-
cipant’s individual healthcare needs, diagnoses (including
QTF classification [61]), priorities and tolerance level, to
change treatments over the course of the study as clinically
indicated, and for treatments to vary between participants
within study groups as they would in clinical practice.
When spinal manipulation is considered clinically appro-
priate, the DC makes decisions regarding the specific tech-
nique, application (location and direction), and areas for
manipulation [76]. While this study is focused on LBP,
participants also may receive chiropractic treatments to
other parts of the body, such as the neck, upper back or
extremities. The DC may employ one of several forms of
spinal or extremity joint manipulation, including but not
limited to: 1) high-velocity, low-amplitude maneuvers
occurring with direct manual contact, typically resulting in
cavitation [77]; 2) low-velocity, variable-amplitude maneu-
vers occurring slowly and usually repetitively within
defined ranges of motion [73,74]; 3) very high-velocity,
low-amplitude maneuvers using a mechanical device
(ActivatorW Methods International, Phoenix, AZ, USA)
[78]; or 4) passive mobilization [24,79]. All treatment is
performed with specialized chiropractic treatment tables
(Eurotech, Osage Beach, MO, USA and Thomas Table
Company, Davenport, IA, USA). The care provided is
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for the treatment of LBP in older adults; no experimental
chiropractic treatments are provided in this study
[24,50,80,81]. Chiropractic care also may include rehabilita-
tion exercises (attended or at-home), passive stretching,
neuromobilization techniques, manual therapies (for ex-
ample, ischemic compression, friction massage), counseling
(movement, activity, ergonomic and nutrition), recommen-
dations for orthotics, or other modalities (for example,
heat, ice, taping, bracing) [82-85]. Rehabilitation exer-
cises may be prescribed using a FitBALL Seating DiscW
(Ball Dynamics International, LLC, Longmont, CO, USA)
or Thera-BandW equipment (The Hygenic Corporation,
Akron, OH, USA) and may include handouts to reinforce
teaching (Visual Health Information, Tacoma, WA, USA).
As the same group of research clinicians delivers chiroprac-
tic care to participants in both the Dual Care and Shared
Care Groups, the way this care is delivered should not vary
appreciably from a technical standpoint between study
participants.
Participants are not charged for the chiropractic care
delivered in this study, but may be required to pay on
their own or to individually submit bills to Medicare or
their insurance companies for co-interventions such as
orthotics, monitored exercise programs or special equip-
ment recommended by the DC. The minimum dose of
chiropractic care is one treatment visit to the doctor of
chiropractic. The typical chiropractic treatment visit is 15
to 30 minutes in duration, with the DC making recommen-
dations regarding treatment frequency (for example, one,
two or three times per week) and duration (for example,
number of weeks) as the participant progresses through the
12-week active care phase.
Collaborative care treatments
While both Dual Care and Shared Care participants
receive a combination of the medical and chiropractic
treatments listed above, only participants in the Shared
Care Group are cared for by a doctor dyad composed of
a medical or osteopathic family medicine resident
physician from GFMC and a doctor of chiropractic from
the PCCR who work together along with the participant
to determine a shared treatment plan. The Shared Care
clinician dyad practices a theory-based, patient-centered,
collaborative care model composed of three unique
elements: 1) Interprofessional Education, 2) Research
Record Sharing and 3) Team Case Management.
Interprofessional Education – The Interprofessional
Education Collaborative recently declared interprofes-
sional education and interactive learning among the
health professions as essential components for the deliv-
ery of safe, high quality, patient-centered healthcare [86].
Core competencies for interprofessional collaborative
practice under this initiative include: a) values andethics; b) knowledge of roles and responsibilities; c)
communication; and d) teamwork competencies. These
interprofessional practice competencies dovetail with the
Hsiao et al. model of provider attitudes and knowledge,
interdisciplinary referral and integrative practice beha-
viors that guides this pilot project [35].
An initial group of Shared Care clinicians completed a
six-month interprofessional educational program which
included cooperative training sessions led by study
investigators and other project personnel [87]. Sessions
included the following topics: basic educational prepar-
ation and advanced training for medical physicians and
doctors of chiropractic [88]; LBP overview in older adult
populations [50,89]; medical and chiropractic treatments
for LBP; and imaging studies for LBP. These didactic
presentations were complemented by interdisciplinary
discussions of simple and complex cases for LBP suitable
for co-management by family medicine physicians and
doctors of chiropractic. Additional topics covered
included protection of human research participants
training [53]; results of focus groups conducted with
clinic-based older adults on the topic of LBP and its co-
management by family medicine physicians and DCs;
and overviews of the clinical trial, including clinical trial
fundamentals, manual of operating procedures, STaRS,
flow chart, treatment procedures, and data collection
forms and procedures.
All Shared Care clinicians also completed a half-day
site visit at the partner clinic to job shadow one or more
doctors during a typical day treating patients to develop
interprofessional collaborative relationships [90]. When
time allowed, GFMC doctors joined a case review ses-
sion for clinical trials currently in progress at the PCCR
to observe how BL2 evaluations would support the eligi-
bility determination process. In addition, study investiga-
tors led quarterly interprofessional education sessions to
discuss clinical trial progress, resolve implementation
barriers identified throughout the study, and introduce
new collaborative care topics of interest as the study
progresses, such as medication management for older
adults and rehabilitation options for persons with LBP
throughout the trial implementation period. Training
boosters on specific trial components and interprofes-
sional communication procedures are provided as
needed by the project manager, PCCR senior clinician
and GFMC faculty.
Research Record Sharing – The Institute of Medicine
has long advocated for the adoption of computer-based
patient record systems by healthcare organizations as an
essential technology for improving healthcare delivery
and patient care outcomes [91]. Key stakeholders in
leading integrative medicine centers recommend elec-
tronic medical records as a critical administrative struc-
ture for successful integration of CAM and conventional
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also have identified a need for shared clinical documenta-
tion, including case reports, X-rays and other imaging
studies, and additional clinical information, to improve
continuity of care, treatment coordination and interprofes-
sional referrals between primary care doctors and chiro-
practors [30,31]. Thus, an innovative infrastructure
component of this collaborative care model is the use of a
web application Doctor Communications module to allow
secure, convenient availability and access of participant
research records between Shared Care clinicians located at
the two geographically distant and institutionally distinct
research sites. Shared Care clinicians may access the
following research records throughout a participant’s in-
volvement in the active care phase of the trial: past medical
and chiropractic history, pain history, medications check-
list, radiology reports (if available), outside medical reports
(when present), BL1 and BL2 exam summaries, treatment
summaries, telephone consultations and change of status
reports. Shared Care clinicians and support personnel
receive automated e-mail notifications when research-
related documents are uploaded and available for review.
Team-Based Case Management – Each Shared Care
participant is assigned to a team of treating clinicians
(MD/DO and DC) who follow the participant’s progress
throughout the 12-week active care phase. Some partici-
pants may receive care from more than one MD/DO or
DC due to scheduling logistics. Following the partici-
pant’s first treatment visits to both the GFMC and PCCR
clinics, the Shared Care clinicians each prepare and up-
load initial case summaries onto the secure website, and
arrange an interprofessional telephone consultation to
discuss the participant's past health history and current
case presentation, individual goals, anticipated progress
and treatment recommendations. A Shared Care treat-
ment plan is mutually established and the doctor who
next sees the participant discusses these recommenda-
tions with the participant and incorporates any feedback
into the overall treatment plan and communicates such
changes to the Shared Care treating partner. Each
Shared Care clinician is familiar with the treatment plan
and provides the participant with encouragement, advice
and support for both the individual’s goals and the general
direction of the co-management treatment plan [93]. Add-
itional telephone call consultations or research record
exchanges may be initiated for Shared Care participants
by either treating clinician throughout the study as the
participant's condition, response to medical or chiroprac-
tic treatment, or need for referral to primary care provider
or health specialists warrant.
Outcome measures
Outcomes are measured by participant self-report, object-
ive assessment, and in-person and telephone interviews.Outcomes are collected at baseline, 4, 8 and 12 weeks
(primary endpoint), and every 12 weeks thereafter for up to
one year (weeks 24, 36 and 52). The baseline visits and
12-week evaluations are scheduled as in-person visits at
each clinic. At these visits, a SC administers the self-report
questionnaires and interviews to the participant and cleans
the data per protocol. Study clinicians (MD/DO and DC)
perform the objective clinical assessments. DC exams are
conducted by examining clinicians who do not treat partici-
pants as part of this trial; GFMC treating physicians
complete the 12-week MD/DO exams with their assigned
participant to maintain continuity of care. Due to logistical
constraints with the doctors’ schedules, pre- and post-
evaluations may not necessarily be completed by the same
clinicians. A semi-structured qualitative interview is con-
ducted by the project manager or SC at the PRC during the
12-week evaluation after completion of all other assess-
ments to understand the participant’s perceptions of back
pain improvement, clinical trial experience, expectations,
treatment effects and interprofessional collaboration among
the treating clinicians. We attempt to obtain outcome data
from all trial participants, even those who decide to not
attend treatment visits, drop out of care or move away from
the area. If a participant is unable to attend the 12-week
visit in person, the primary outcome measures and a subset
of secondary outcomes are administered via CATI or
paper-based questionnaires sent to the participant’s home
with a stamped return envelope.Self-report outcome measures
Participant-rated pain is a primary outcome measure
[52]. Participants rate their average level of LBP in the
past week and their worst level of LBP in the past week
on an ordinal, 11-point numerical rating scale (0 = no
LBP; 10 = worst LBP possible) during the phone screen;
at the BL1 and BL2 Visits, and BL3 CATI; and all
follow-up assessments [94]. The NRS has excellent
metric properties, is easy to administer and score, and is
used often in LBP research [95,96]. The minimal clinic-
ally important difference (MCID) for the pain NRS is a
change of 2.5 points [96].
Participant-rated LBP disability also is a primary outcome
measure. We use the 24-item Roland Morris Disability
Questionnaire to assess LBP-related disability [58,97,98].
The one-page RMDQ is among the most common and
respected LBP assessment instruments in LBP outcomes
research and exhibits well-documented reliability and valid-
ity [52]. The RMDQ can discriminate between different
forms of treatment for back pain and is sensitive to clinical
change [99,100]. The MCID of the RMQD is estimated at
two points [101]. We are piloting three LBP-disability ques-
tions not captured by the RMDQ but that represent com-
mon functional limitations in LBP populations: difficulty
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driving a motor vehicle [102].
Participant-rated secondary outcome measures include
general health status, fear avoidance, symptom bother-
someness, depression and anxiety, functional mobility,
expectations, improvement, satisfaction, health care
utilization and medication use.
General health status is collected with the Veterans
RAND 36-item Short Form Health Survey [103,104] to
assess changes in physical functional and mental health
from baseline levels at 4, 8 and 12 weeks of care.
The Fear Avoidance Beliefs Questionnaire (FABQ) is a
16-item instrument measuring back-pain fears on two
subscales related to Physical Activity and Work which
are rated from 0 (completely disagree) to 6 (completely
agree). The FABQ has demonstrated reliability and validity
in chronic LBP populations, with lower FABQ scores indi-
cating the probability of successful treatment with spinal
manipulation [105-107]. The FABQ is used to assess
change in LBP fears from the BL1 visit to the 12-week
evaluation.
Symptom bothersomeness is a common quality of life
measure for LBP studies. Participants rate the bother-
someness of their back pain symptoms as well as any
depression symptoms during the past week, with each
symptom measured on a 1 to 5 scale, where 1 = not at
all bothersome and 5 = extremely bothersome. A symptom
bothersomeness index is calculated by summing five symp-
tom ratings. Bothersomeness questions are practical and
have demonstrated internal consistency, construct validity
and responsiveness to change in patients with LBP [108].
Mental health outcomes are measured at baseline and
week 12 with the Patient Health Questionnaire-9 for de-
pression and the General Anxiety Disorder-7 for anxiety
[67,68]. The Patient Health Questionnaire-9 is a brief
screening instrument based upon the Diagnostic and
Statistical Manual (DSM-IV) and adapted from studies
for assessing depression symptoms and severity in
primary care settings [109]. The nine-item tool is scored
on a 0 to 3 scale with total scores ranging from 0 to 27
and a MCID of five points. The General Anxiety
Disorder-7 is a short, self-report instrument for the
clinical assessment of generalized anxiety disorders [68].
The seven-item tool is scored on a 0 to 3 scale with total
scores ranging from 0 to 21.
Functional mobility is measured at baseline and week
12 with the Timed Up and Go Test [60]. This brief
screening tool is used to identify older adults with
poorer functional mobility and those who are prone to
falling [110]. During the test, the participant rises from a
chair, walks 10 feet, turns around, walks back to the
chair and sits down while the observer times the trial.
Health care utilization is based upon participant self-
reported estimate of their use of additional health careservices and out-of-pocket costs for LBP, including the
provider types, number of visits, and description of services
or products at baseline and all follow-up assessments.
Medication use, including current non-prescription
and prescription medication as well as dietary and nutri-
tional supplements, is assessed by participant self-report
at baseline and all follow-up time points.
Participant satisfaction with care received during the
trial is rated on an investigator-designed instrument
that is based on common elements of satisfaction
reported in the LBP literature [111]. Overall satisfaction
with care is rated on an 11-point NRS with the anchors
“not at all satisfied” to “extremely satisfied”. Participants
also rate their satisfaction with seven different aspects
of back pain care on a five-point Likert scale (1 = poor;
5 = excellent): information received regarding the cause
and prognosis of LBP; information received regarding
activities that would hasten recovery and prevention of
future LBP problems; concern shown by the provider;
quality of treatment recommendations; and overall care
for LBP. Participants also complete a seven-point Likert
scale (0 = very poor; 6 = the best) that assesses their
satisfaction with clinic convenience, as well as the
technical skills, listening skills, and the amount of time
spent with the clinicians and research staff. For partici-
pants in the Dual Care and Shared Care groups, care
satisfaction is rated for both the treating DC and MD/
DO, while Med Care group participants only rate their
satisfaction with medical care.
Participant expectations of treatment and LBP im-
provement are assessed with an adapted questionnaire
from a study of the effect of expectations on the evaluation
of effectiveness of acupuncture and massage among LBP
patients [112]. Participants rate the perceived helpfulness of
five treatment options (for example, medical care, chiro-
practic care, physical therapy, concurrent medical and
chiropractic care, and collaborative medical and chiroprac-
tic care) for improvement of their LBP on an 11-point NRS
with the anchors “not at all helpful” to “extremely helpful”
at the BL1 Visit. Participants also rate their expectations
about LBP improvement three months from baseline on a
seven-point scale anchored with “completely gone” to
“much worse”, as well as expectations for improvement in
their overall health status and quality of life on a seven-
point scale anchored with “very much improved” to “very
much worse”. We repeat the questions about expected
improvements in LBP, overall health status and quality of
life during the BL3 CATI to assess whether participant
expectations for improvement change after allocation to a
treatment group. At the 12-week visit, participants rate the
level of improvement they achieved in each of these three
domains since the start of the study.
Clinician expectations of care and LBP improvement:
Because this is among the first studies to evaluate the
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and doctors of chiropractic in the treatment of patients
with chronic LBP, we also are interested in clinicians’
expectations of care and LBP improvement for these
participants [113]. The DC and MD/DO clinicians who
perform the baseline examinations rate expected
improvement from each of the five LBP treatment
modalities on the same 11-point NRS described above
for participant expectations. These clinicians also rate
their expectations for improvement in the participant’s
LBP, overall health status, and quality of life on the same
seven-point scales identified above. Examining clinicians
complete a brief narrative text box to describe their
rationale for the care and LBP improvement expecta-
tions they hold for the participant. Treating DC and
MD/DO clinicians complete these same questionnaires
after the first treatment visit.
Blinding
As this is a RCT evaluation for three models of interpro-
fessional practice between medical physicians and DCs,
the study participants, study coordinators or treating
clinicians are not blinded to the participant’s treatment
allocation. The primary and most of the secondary
outcome measures are self-administered questionnaires
distributed by the study coordinators. Participants
complete these questionnaires on their own in a consult
room at the Baseline Visit 1 and at the Month 3 evalu-
ation. The Timed Up and Go Test is completed at these
visits by an examining clinician who has not provided
care to the participant during the 12-week active care
phase of the study. Other follow-up assessments are
collected via CATI conducted by trained interviewers
who do not provide study treatments and who are
masked to participant outcomes assessment data from
all other time points. Study clinicians remain blinded to
participants’ outcome data for the entire study period.
All analysts and study investigators are blinded to treat-
ment group until data analysis is completed.
Qualitative interviews
Participants complete an individual qualitative interview
at the end of the 12-week active care phase following all
other outcome measures [114]. A semi-structured inter-
view schedule guides the interview process with follow-up
probes used to elicit the participant’s unique experiences in
the clinical trial. In most cases, the project manager (who
does not have day-to-day contact with participants) com-
pletes the interview session to encourage participants to
speak freely about their experience in the study. When the
project manager is not available, a SC trained in the inter-
view protocol conducts the interview. Participants are
asked questions about their interest in the clinical trial;
overall experience in the study; treatment expectations andeffect of treatment allocation on those expectations;
perceived changes in back pain and other health conditions
during active care; potential impact of illnesses, injuries or
other setbacks on LBP progress and quality of life; treat-
ment likes and dislikes; relationship with medical doctor
and/or doctor of chiropractic; and perceptions of the
collaborative care process. Participants provide written
consent at the time of the informed consent procedure and
verbal permission to audio-record the qualitative interview
at the start of the session. To assure confidentiality, inter-
views are conducted in a private consult room with the
door closed, participants are not identified by name during
the interview, and only the participant ID number marks
the audio-recording and transcripts. In addition, we con-
duct exit interviews with interested medical physicians and
DCs who provided care to study participants to determine
their perceptions of the feasibility and sustainability of the
study model. All interviews are transcribed verbatim by
an independent transcription service, reviewed for com-
pleteness and accuracy by the project manager, and
imported into a qualitative data analysis computer data-
base (NVivo-9, QSR International Pty Ltd., Doncaster,
VIC, Australia) for analysis.
Data management
The DCC handles the data management procedures for
this clinical trial using modifications of data handling
procedures described elsewhere [62]. The STaRS is
comprised of multiple sub-modules integrated into one
comprehensive study management web application that
includes CATIs for phone screens and follow-up data
collection, participant eligibility checks, treatment
allocation, participant tracking, a tickler system, report
generation and scheduling. The ASP.NET web applica-
tion elements were programmed in C# and Structured
Query Language (SQL) using Microsoft Visual Studio
2005 (Microsoft, Redmond, WA, USA) and Microsoft
SQL Server Management Studio (Microsoft). User-friendly
data entry interfaces were programmed with appropriate
participant flow restrictions, validation schemes and skip
patterns. The STaRS interfaces with the Central Participant
Database and uses a Project/Users Permissions System to
control project personnel access to web modules. The DCC
added the Doctors’ Communication module to facilitate the
secure transfer of participant research records and to pro-
vide file posting updates with automated e-mail notification
to the DC and MD/DO clinicians who collaborate on LBP
care for participants in the Shared Care group, as well as to
the GFMC research nurse and PCCR project manager and
senior clinician.
Participant self-report questionnaires and clinician-
completed progress notes are paper-based forms. Research
outcomes data collection paper forms include only the
unique numerical participant ID as an identifier. Study
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forms, log each completed form into the form tracking
module of STaRS, and submit data forms for key-entry.
The project manager transfers paper records from the
medical clinic to the DCC on a weekly basis. Forms are
also transferred between clinics on secure fax systems.
Paper data collection forms and participant research
record charts are stored in locked filing cabinets at each
clinic. Trained data-entry clerks double key-enter paper
forms in a Microsoft WindowsW (Microsoft) program
using range and validation checks.
The STaRS web system is password-protected and uses
a MicrosoftW SQL Server (Microsoft) database platform
to store all data. Web programmers collaborated with
project personnel to gather system requirements and
designed the web applications and database structures
based on PCCR standards. DCC personnel developed
the electronic data collection forms, programmed web
applications to support data and project management,
provide data form key-entry and technical support, and
execute procedures for data security and data quality
control, storage and back-up. The Data Manager main-
tains the data dictionaries and creates the datasets for
analysis.
Participant enrollment data are collected at each stage
of the clinical trial from initial phone screen through
treatment allocation to the 12-week primary endpoint
and 52-week follow-up period, so participant flow is
reported according to CONSORT guidelines [62]. Specif-
ically, we collect recruitment source, total responses per
recruitment source, race/ethnicity and gender distribu-
tion, disposition status (for example, ineligible, does not
wish to participate, allocated, withdrawal, completed
active care, completed follow-up, lost to follow-up),
reasons for non-participation or exclusion (for example,
current treatment, cost, treatment allocation, perceived
benefit, travel, health concerns, baseline exam results,
multiple/other and so on), and the number allocated to
each treatment group [66].
Data management and quality control of both key-
entered forms and web forms are performed using SQL
views, stored procedures and real-time, web-based reports.
Automated reports are viewed by the data manager and
project manager to determine if quality improvement
actions must occur, such as improved documentation,
protocol revisions or personnel retraining. Final project
datasets of combined web and paper data are assembled by
transferring data from MicrosoftW SQL Server (Microsoft)
to SAS System for Windows (Release 9.2, SAS Institute
Inc., Cary, NC, USA). The data manager writes and tests
SAS programs to create datasets as requested by the inves-
tigators and creates the data dictionaries. DBMS Copy
(Conceptual Software, Houston, TX, USA) software is used
to move the data across software applications.Data and safety monitoring
A Data and Safety Monitoring Committee (DSMC)
provides scientific and ethical oversight on all ongoing
human clinical trials conducted by the PCCR. The
DSMC currently is composed of epidemiologists with
expertise in LBP and/or CAM clinical trials, a medical
physician, a doctor of chiropractic and a biostatistician,
none of whom are employed by PCCR or GFMC. The
DSMC approved the study protocol, informed consent
document and human research participant protection
procedures before trial implementation. To monitor trial
data, the DSMC reviews status reports prepared by the
trial biostatistician that include recruitment accrual,
enrolled participant baseline characteristics and other
enrollment data; data collection form processing; follow-
up assessment completion; treatment compliance; study
protocol deviations and other clinical trial data. To
monitor participant safety, the DSMC reviews reportable
adverse events (see below) every six months and assesses
any serious adverse events upon report receipt. No
formal stopping rules were established in advance of trial
implementation. The DSMC may make recommenda-
tions to the principal investigator and funding agency
regarding study progress, termination or trial modifica-
tions. We also report serious adverse events to the fund-
ing agency following receipt of the report.
Adverse events and UPIRTSOs
An IRB-approved adverse event (AE) grading and
reporting protocol defines the processes by which AEs
are monitored and categorized in this clinical trial. This
protocol also outlines when and how participant safety
concerns are reported to the IRBs, DSMC and funding
agency. An AE is defined as any untoward medical
occurrence that may present itself during the conduct of
the study and that may or may not have a causal rela-
tionship with study procedures [115]. A serious adverse
event is defined as an adverse event resulting in any of
these outcomes: death, a life-threatening adverse experi-
ence, hospitalization or significant disability/incapacity
[115]. A previous clinical trial of six weeks of chiroprac-
tic care or medical care for persons over age 55 years
with LBP reported no serious adverse events associated
with any of the interventions and only 21 side effects in
20 participants among 240 randomized participants [27].
Our research center uses an active process of clinical
surveillance [116] to monitor adverse events and other
changes in participant health status throughout the
course of our studies. Research clinicians, SCs and the
GFMC research nurse receive ongoing training on AE
identification, grading, reporting and monitoring. Parti-
cipants also are instructed to report new symptoms or
changes in health status to the research team at each
treatment visit and to contact the clinics in the event of
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may be related to study treatments. Research clinicians
monitor participant safety by conducting clinical evalua-
tions of health status and querying participants for new
symptoms or other changes in health status, alterations
in prescribed or self-care treatments, and the develop-
ment of any untoward effects from study interventions
at each treatment visit and all follow-up assessments.
When AEs are suspected, the treating DC at the PRC or
the research nurse at GFMC completes an AE monitoring
form which includes a description of the event, date of
onset, impact of prognosis and referral to outside care.
The clinician or nurse then rates whether an AE is: 1)
mild, moderate, severe or serious in severity; 2) expected
(disclosed in the informed consent document or part of an
underlying disease) or unexpected (more serious than
expected, or not disclosed in informed consent document);
and 3) related to the intervention (for example, definitely,
probably, possibly, unlikely or unrelated). AEs are followed
to resolution at which time an AE resolution form is
completed. An automated web-based system records all
AEs to allow the project manager and senior clinician to
track and report adverse events to the principal investigator,
both IRBs of record, DSMC and funding agency.
We also monitor and report Unanticipated Problems
Involving Risks to Subjects or Others (UPIRTSOs).
Federal regulations (45CFR46.103(b)(5) and 21CFR56.108
(b)(1)) require study investigators to promptly report
UPIRTSOs to local IRBs. The Palmer College of Chiro-
practic IRB defines UPIRTSO as any problem or event
that in the opinion of the local investigator was
unanticipated, serious and at least possibly related to
the research procedures.
Sample size justification
The sample size of this pilot randomized controlled trial
was selected as a minimum of 120 participants with
equal allocation to each of three treatment groups. This
sample size should provide adequate participant contact
in each treatment group to assess and refine the collabora-
tive care model, determine the feasibility of conducting a
full-scale trial and obtain reasonable estimates of effect sizes
and variability to use in powering a full-scale trial. Although
the sample size was not chosen to detect between group
differences, the power of the study to detect differences of
2 points on the RMDQ and 2.5 points on the NRS with 40
participants per group, assuming at least 85% of partici-
pants complete the 12-week primary endpoint assessment,
will exceed 75%.
Data analysis
DCC biostatisticians will conduct the quantitative data
analyses using SAS System for Windows (Release 9.2)
(SAS Institute Inc.) and S-Plus 8.0 for Windows (TIBCOSpotfire, Somerville, MA, USA). Co-investigators with
expertise in interpretive methodologies will conduct
qualitative data analyses of the individual interviews with
study participants using NVivo-9 qualitative data analysis
computer software (QSR International Pty Ltd., Doncaster,
VIC, Australia). Both analytic teams will collaborate with
the investigators in presenting and interpreting the results.
Quantitative data analysis
Descriptive statistics of participant baseline characteristics
will be presented for each treatment group to assess their
comparability. Descriptive statistics of the primary and
secondary outcome variables will be presented for each
treatment group at baseline, and weeks 4, 8 and 12
(primary end point), and for follow-up measures at weeks
24, 36 and 52.
We will estimate mean effects of the primary outcome
variables by modeling over weeks 4, 8 and 12, adjusting
for the baseline measure. Linear mixed models will be
used to examine patterns and estimate effects between
groups after fitting models that account for the correl-
ation across measurements in the same participant. The
adjusted mean differences and 95% confidence intervals
between groups at week 12 will be based on the final
models. Intention-to-treat analyses will be used; the ana-
lyses will use data for every time point that a participant
completes.
Point estimates with 95% confidence intervals will be
reported for pairwise differences between groups on the
secondary outcome variables. We will not control for
multiple comparisons in this study, but will use these
pilot data to determine the most efficient design and
estimate the sample size needed, accounting for multi-
plicity issues, for a full-scale trial. Although we will not
impute missing data for analysis of these data, we will
examine for patterns of missingness to guide the missing
data analysis plan for a full-scale trial.
Qualitative data analysis
We will analyze individual interview transcripts through
a two-stage process using conventional and directed
content analysis techniques [114]. First, we will use an
inductive approach to identify broad topics in the tran-
scribed text, coding each question to identify such
themes as motivations for study participation; treatment
expectations; collaborative care process; doctor-patient
relationship; treatment adverse effects; and perceived
treatment benefits. For topics with more substantive
theory, we will use a template-style coding process to
create a code manual, computer code the text, sort simi-
lar text into groupings for reading, and verify coding
structure [114]. We will compare participant responses
within and across treatment groups to identify areas of
consensus and variation in participant experience.
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through prolonged engagement with the texts and coding
process, triangulation, and the use of multiple coders and
peer debriefing [117].
Discussion
This pilot study protocol describes the design of an
innovative randomized controlled trial to evaluate the
clinical effectiveness and feasibility of three professional
practice models for the treatment of older adults with
low back pain by family medicine physicians and doctors
of chiropractic. To the best of our knowledge, this
randomized controlled trial is the first to compare
patient-centered outcomes for older adults with LBP re-
ceiving conventional medical care, co-occurring medical
and chiropractic care, or collaborative medical and
chiropractic care. Our study design has several strengths.
The study protocol is based upon interdisciplinary
evidence-based, clinical practice guidelines for the care
of patients with back pain. The population under study,
older adults aged 65 years or older represent some of
the most challenging LBP patients as they often present
to their primary care providers and doctors of chiropractic
with multiple co-morbid conditions and decades-long
treatment histories. Our rigorous eligibility determination
process paired with individualized medical and chiropractic
treatments allowed the inclusion of complex back pain
patients as participants in this study, which reinforces its
pragmatic design. In addition, our multi-stage eligibility
process is designed, described and documented so that an
independent group of researchers, if they followed the
description provided, would recruit sufficiently similar par-
ticipants. With further development and refinement, the
exploratory model of provider-level integrative medicine
used to guide the interprofessional collaboration between
the family medicine physicians and doctors of chiropractic
in this study may serve as an example for healthcare
organizations seeking to integrate conventional and CAM
services in real world settings.
Trial status
Participant recruitment began 04 March 2011. The first
participant was allocated on 05 April 2011. The final
participant was allocated on 21 August 2012. The active
care phase of the trial ended in November 2012. The
six-month follow-up period will end March 2013.
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